Blue Jet Healthcare Limited (BLUEJET) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Blue Jet Healthcare Limited (BLUEJET) has a cash flow conversion efficiency ratio of 0.165x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs2.07 Billion ≈ $22.41 Million USD) by net assets (Rs12.56 Billion ≈ $135.80 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Blue Jet Healthcare Limited defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Blue Jet Healthcare Limited - Cash Flow Conversion Efficiency Trend (2020–2026)
This chart illustrates how Blue Jet Healthcare Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Blue Jet Healthcare Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Blue Jet Healthcare Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sweetgreen Inc
NYSE:SG
|
-0.004x |
|
Berliner Effektengesellschaft AG
F:BFV
|
N/A |
|
Ulker Biskuvi Sanayi AS
IS:ULKER
|
0.050x |
|
Bright Real Estate Group Co Ltd
SHG:600708
|
-0.004x |
|
Foshan Electrical and Lighting Co Ltd
SHE:000541
|
0.003x |
|
Silicon Integrated Systems Corp
TW:2363
|
-0.001x |
|
INVENTIVA ADS/1 O.N.
F:6IVA
|
N/A |
|
Rezolve AI Limited Ordinary Shares
NASDAQ:RZLV
|
-0.176x |
Annual Cash Flow Conversion Efficiency for Blue Jet Healthcare Limited (2020–2026)
The table below shows the annual cash flow conversion efficiency of Blue Jet Healthcare Limited from 2020 to 2026. For the full company profile with market capitalisation and key ratios, see market value of Blue Jet Healthcare Limited.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs13.60 Billion ≈ $147.07 Million |
Rs3.38 Billion ≈ $36.56 Million |
0.249x | +515.48% |
| 2025-03-31 | Rs11.33 Billion ≈ $122.54 Million |
Rs457.65 Million ≈ $4.95 Million |
0.040x | -85.85% |
| 2024-03-31 | Rs8.45 Billion ≈ $91.41 Million |
Rs2.41 Billion ≈ $26.09 Million |
0.285x | +37.42% |
| 2023-03-31 | Rs6.81 Billion ≈ $73.70 Million |
Rs1.42 Billion ≈ $15.31 Million |
0.208x | -26.01% |
| 2022-03-31 | Rs5.22 Billion ≈ $56.40 Million |
Rs1.46 Billion ≈ $15.83 Million |
0.281x | -26.57% |
| 2021-03-31 | Rs3.40 Billion ≈ $36.75 Million |
Rs1.30 Billion ≈ $14.05 Million |
0.382x | -36.84% |
| 2020-03-31 | Rs2.03 Billion ≈ $21.93 Million |
Rs1.23 Billion ≈ $13.27 Million |
0.605x | -- |
About Blue Jet Healthcare Limited
Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance… Read more